Par Pharmaceutical: Brevital Sodium 500 mg/vial for Injection
Presence of particulate matter identified as cellulose
- Recall
6 indexed FDA medicines recalls naming Par Pharmaceutical, 2024–2026, newest first, each linking through to the official notice.
2 notices
Presence of particulate matter identified as cellulose
Presence of particulate matter identified as cellulose or stopper material
4 notices
Product is an unapproved drug.
Mislabeled with the incorrect strength on the carton
Mislabeled with the incorrect strength on the carton
Potential Presence of Silicone Particulate Matter
Advertisements
A list of notices is not a check of your own product. Compare the identifiers in the official notice with the product you have.
FDA: Public announcements only; not the complete FDA Enforcement Report database or historical archive. Source coverage explains which notices are indexed and when each source was imported.
Medicine recalls has the full checking guide and every indexed notice in this category.